A large body of evidence implies that the abnormal accumulation of APP-related products, such as CTF and Aβ, initiate intraneuronal communication in AD within vesicles of the endosomal–lysosomal (endolysosomal) pathway, which mediates both the generation and degradation of APP-derived products. This evidence concerns the gene APP and Alzheimer disease.